Kao-bis
NDC Package 53807-503-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Kao-bis is shake well before each usedrink plenty of clear fluids to help prevent dehydration caused by diarrhearepeat dosage every 1/2 to 1 hour as neededdo not take more than 8 doses in 24 hoursuse until diarrhea stops but not more than 2 daysadults & children 12 years and over: 2 tablespoons (30 mL)children under 12 years: ask a doctor. Marketed by Rij Pharmaceutical Corporation, this product is identified by NDC 53807-503 and is authorized under FDA application part335.

Identification & Billing

NDC Package Code
53807-503-08
Package Description
237 mL in 1 BOTTLE
Product Code
53807-503
11-Digit Billing Format
53807050308
RxNorm Crosswalk
  • RxCUI: 308762 - bismuth subsalicylate 525 MG in 30 mL Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 17.5 MG/ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 1.75 % Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 262 MG per 15 ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 524 MG per 30 ML Oral Suspension

Clinical Specifications

Proprietary Name
Kao-bis
Dosage Form
-
Usage Information
Shake well before each usedrink plenty of clear fluids to help prevent dehydration caused by diarrhearepeat dosage every 1/2 to 1 hour as neededdo not take more than 8 doses in 24 hoursuse until diarrhea stops but not more than 2 daysadults & children 12 years and over: 2 tablespoons (30 mL)children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Rij Pharmaceutical Corporation
FDA Application #
part335
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-16-1999
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (53807-503). Click a package code to view its specific billing and regulatory data.

53807-503-12
355 mL in 1 BOTTLE
53807-503-16
473 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53807-503-08 identifies a specific commercial package of 237 ml in 1 bottle of Kao-bis, labeled by Rij Pharmaceutical Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rij Pharmaceutical Corporation on March 16, 1999. The current certification is valid through December 31, 2019.

How is this Rij Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53807050308. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53807-503-08
11-Digit CMS (5-4-2)
53807-0503-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.